Company Explainer:
Unlocking the over-the-counter medicinal cannabis opportunity
CEO of Wellnex Life George Karafotias, Chief Strategy Officer Zack Bozinovski and GM of Regulatory Affairs Chris Kominatos provide a short video update to discuss how Wellnex are positioning themselves in the over-the-counter medicinal cannabis market, as well as a broader company update.
Recorded on 5 October 2022 at 1:00pm (AEDT)
The Future of Medicinal Cannabis Summit
Thursday, 13th October 12pm (AEDT)
Wellnex Chief Strategy Officer Zack Bozinovski has been invited to join a panel discussion on ‘The Insider: Future of Medicinal Cannabis’ Summit, alongside Shane Duncan, COO of Cann Group (ASX: CAN) on Thursday, 13th October at 12pm (AEDT).
In this session, they will discuss:
- Why they believe over-the-counter medicinal cannabis is potentially one of the biggest opportunities in Australian pharma in recent times
- The opportunity that is unlocked as TGA moves to approve over-the-counter products and how businesses are positioning themselves
- The challenges and key milestones to getting TGA approval and successfully taking early market share
This is a live and interactive online session, and participants are encouraged to ask questions. Spots are limited, so secure yours today.
Book Your Spot
What is a 708 investor?By clicking submit, I agree to the terms of the Reach Markets Financial Services Guide that includes the Privacy Statement. Reach Corporate provide Corporate Advisory Services to Wellnex Life Limited and has been engaged by them to manage their investor communications including managing this offer and may receive fees for its services.
